// App-Quantinova.ai

: CRYPTOGENIC STROKE SECONDARY TO BIG CHIARI NETWORK IN A PATIENT WITH PATENT FORAMEN OVALE

Researchers

Presenter

  • Amandeep Goyal

Principal Investigators

  • Tarun Dalia

  • Jonathan Chandler

  • Sagar Ranka

  • Prince Sethi

  • Prakash Acharya

  • Thomas Rosamond

  • Zubair Shah

Medical Centers

  • University of Kansas Medical Center, Kansas City, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

Disease

  • Deep vein thrombosis

  • Atrial septal defect

  • Venous thrombosis

  • Arrhythmia

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

  • Heparin

  • Clopidogrel bisulfate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A